• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Retrograde Recanalization of a Chronic Total Occlusion of the Posterior Tibial Artery

  • Tue, 5/18/10 - 11:25am
  • 3353 reads
  • 0 comments

A 69-year-old male was evaluated for a non-healing ulcer of his right foot. His comorbidities included end-stage renal disease on dialysis, diabetes, coronary artery disease, permanent pacemaker implantation and known peripheral vascular disease with previous left above-the-knee amputation. On examination, he had only a faint distal pulse on the right lower extremity.

Peripheral angiography was performed via the left (contralateral) groin. The superficial femoral artery (SFA) showed no critical stenosis. The deep femoral artery was 100% occluded, the anterior tibial artery was 100% occluded, and the posterior tibial and the peroneal arteries were 100% occluded as well. In the posterior tibial artery, there was a fairly short and calcified segment after the 100% occlusion. Filling to the plantar vessel was present, however, there was delay. Because of the total occlusion of the deep femoral artery, the anterior tibial, posterior tibial and peroneal arteries, the patient was totally dependent on the SFA. Clearly, he was at high risk for above or below the right knee amputation. An attempt was made at revascularization.

A contralateral approach via the left side was first attempted using a .018 Asahi wire (Asahi, Abbott Vascular), but this was unsuccessful. Using a micropuncture, we attained access to the posterior tibial artery using a sheathless system. We went in with a 4 Fr Glide catheter and the .018 Asahi wire (Abbott Vascular). With the Glide catheter support we were able to pass into the popliteal artery into the true lumen. We then exchanged for a Cougar wire (Medtronic, Inc.) and placed a 3.0 Monorail balloon to inflate at the site of the total occlusion. Unable to achieve good patency, we went in with an AngioScore 4.0 x 40 mm balloon (AngioScore, Inc.). There was still inadequate filling; in fact, a large piece of calcification at the site of the total occlusion was observed. The only option was to use a self-expanding stent to salvage this patient’s leg. Thus, a 4.0 mm x 60 mm self-expanding Abbott stent was deployed and then further dilated with the AngioScore balloon, with excellent results: the residual stenosis had decreased from 100% to 0%. There was excellent filling all the way to the foot, including the plantar arteries. The catheter was then removed from the posterior tibial artery and used manual pressure for closure.

This is a case of successful recanalization of a chronic total occlusion (CTO) using a retrograde approach via the posterior tibial artery. CTOs of the lower extremities represent some of the more challenging lesions, are time-consuming and have higher complication rates. Endovascular recanalization of chronically occluded lower-extremity vessels should always be attempted using an antegrade approach first. For those who fail at a concerted effort at antegrade recanalization and have limited surgical options, a retrograde approach is worth the attempt.[1]

Reference

1. Montero-Baker M, Schmidt A, Bräunlich S, et al. Retrograde approach for complex popliteal and tibioperoneal occlusions. J Endovasc Ther 2008;15:594–604.

---------------------------------------------------------------------

Richard R. Heuser, MD, FACC, FACP, FESC, FSCAI, is an internationally-recognized cardiologist, inventor, educator and author. A diplomate of the American Board of Cardiovascular Diseases and American Board of Interventional Cardiovascular Diseases, Dr. Heuser is one of the early pioneers of angioplasty and is considered one of America’s top cardiologists. Dr. Heuser is currently in practice at the Phoenix Heart Center/Physicians Group of Arizona. He is Chief of Cardiology and Chief of Cardiac Catheterization Laboratory at St. Luke’s Hospital and Medical Center, Phoenix, Arizona, and Clinical Professor of Medicine at the University of Arizona College of Medicine, as well as Director of the Interventional Fellowship Program at the University of Arizona College of Medicine, Phoenix Campus.

With 13 patents granted for different catheters, stents and other medical devices, Dr. Heuser has served as principal investigator to research the safety and/or effectiveness of more than 100 medical devices and 70 pharmaceutical products, and has participated in more than 150 research studies. He has authored over 400 articles, textbooks and medical manuscripts, and is frequently invited to international medical conferences to present the findings of research developed in Phoenix.

Dr. Heuser received his medical degree from the University of Wisconsin School of Medicine in Madison, Wisconsin, and completed his medicine internship and residency, as well as his cardiology fellowship

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications